# COUNTY OF VENTURA
# HEALTH CARE AGENCY
# EMERGENCY MEDICAL SERVICES
# COUNTY WIDE PROTOCOLS

**Policy Title:** Nerve Agent / Organophosphate Poisoning  
**Policy Number:** 705.17

**Date Revised:** December 14, 2023  
**Last Reviewed:** December 14, 2023  
**Effective Date:** June 1, 2024  
**Next Review Date:** December 31. 2025

**Approved:** VCEMS Medical Director

---

## SCENE SAFETY

The incident commander is in charge of the scene, and you are to follow his/her direction for entering and exiting the scene. Patients in the hot and warm zones MUST be decontaminated prior to entering the cold zone.

---

## BLS PROCEDURES

### Patients that are exhibiting obvious signs (SLUDGEM) of organophosphate exposure and/or nerve agents

Maintain airway and position of comfort

Administer oxygen as indicated

**Mark I or DuoDote Antidote Kit (If Available)**
- **Mild Exposure:** IM x 1
  - May repeat in 10 minutes if symptoms persist
- **Severe Exposure:** IM x 3 in rapid succession, rotating injection sites

---

## ALS STANDING ORDERS

### ADULT

**When Mark I or DuoDote Antidote kit is not available:**

**Atropine**
- **Mild or Severe Exposure:**
  - IV/IO – 2 mg
  - May repeat q 5 minutes for persistent symptoms

**If CHEMPAK deployed:**

**Diazepam**
- IM/IV/IO – 5 mg
- q 10 minutes titrated to effect
- Max 30 mg

---

### PEDIATRIC

**When Mark I or DuoDote Antidote kit is not available:**

**Atropine**
- **Mild or Severe Exposure:**
  - IV/IO – 0.05 mg/kg mg
  - May repeat q 5 minutes for persistent symptoms

**If CHEMPAK deployed:**

**Diazepam**
- IM/IV/IO - 0.1 mg/kg
- q 10 min titrated to effect
- Max single dose 5 mg
- Max total dose 10 mg

---

## BASE HOSPITAL ORDERS ONLY

Consult with ED Physician for further treatment measures

---

## ADDITIONAL INFORMATION

• DuoDote contains 2.1 mg Atropine Sulfate and 600 mg Pralidoxime Chloride.

• Diazepam is available in the CHEMPACK and may be deployed in the event of a nerve agent exposure.

### Mild Exposure symptoms:

- Miosis, rhinorrhea, drooling, sweating, blurred vision, nausea, bradypnea or tachypnea, nervousness, fatigue, minor memory disturbances, irritability, unexplained tearing, wheezing, tachycardia, bradycardia, SOB, muscle weakness and fasciculations, GI effects.

### Severe Exposure:

- Abnormal behavior, severe difficulty breathing, twitching, unconsciousness, seizing, flaccid, apnea, involuntary defecation, urination.

